Gibson Christopher sold 40,000 shares of RECURSION PHARMACEUTICALS, INC. at $3.08 for −$123k on May 22, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
Director
DIR
Filed May 27, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$123,200Shares × reported price
Shares traded
40,000Class A Common Stock
Price per share
$3.08Reported price. Read footnotes for ranges.
% of reported position traded
4.33%This security and ownership context
Holdings after
883,735Direct
Trade date
May 22, 2026Sell
Filed
May 27, 2026, 4:15 PM ET5-day reporting delay
Accession
0001856369-26-000019Code S · Transaction 88980
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 923,735 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
May 22, 2026Conversion40,000$0.00$0Trade 88981
May 22, 2026Conversion40,000$0.00$0Trade 88979
3 transaction rows in this filing. Joint filers share the same rows.

RXRX price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
RXRX · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +18%1w ago −7.6%1d ago −1.9%
Returns since7d +9.5%30d +11%90d +11%180d1y

Footnotes in full

F1: This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025. F2: Represents the automatic conversion of Class B Common Stock into Class A Common Stock in connection with a sale of the shares by the Reporting Person. Each share of Class B Common Stock is convertible into one share of Class A Common Stock. F3: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F4: The shares are held by LAHWRAN-3 LLC, of which the Reporting Person is a member and a manager. F5: The shares are held by LAHWRAN-4 LLC, of which the Reporting Person is a member and a manager. F6: The shares are held by the Gibson Family Trust, of which the Reporting Person serves as Trustee. F7: The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2025, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter. F8: The option vests as to one forty-eighth (1/48th) of the original 666,898 shares subject to the option on March 1, 2024, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter. F9: The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2023, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter. F10: The option, originally for 416,350 shares, vested as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2022, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter. F11: The option, originally for 1,500,000 shares, vested as to one forty-eighth (1/48th) of the shares subject to the option on January 31, 2021, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter.